Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 2;157(5):218-239.
doi: 10.1177/17151635241267350. eCollection 2024 Sep-Oct.

Role of the pharmacist caring for people at risk of or living with HIV in Canada

Affiliations

Role of the pharmacist caring for people at risk of or living with HIV in Canada

Stacey Tkachuk et al. Can Pharm J (Ott). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Tracy Jansen Cheney: advisory board work for Gilead; Pierre Giguere: speaking honoraria and/or advisory board work for ViiV, Gilead, Merck, Pfizer; Deborah Kelly: speaking honoraria and/or advisory board work for ViiV, Gilead, Moderna; Dominic Martel: speaking honoraria and/or advisory board work for AbbVie, Gilead, Paladin and Pfizer; Carley Pozniak: speaking honoraria and advisory board work for Viiv, Gilead, Merck; Linda Robinson: speaker/educational honoraria, ViiV, Gilead, Merck; Jonathan Smith: advisory board work for ViiV; Alice Tseng: speaking honoraria and/or advisory board work for ViiV, Gilead, Merck, Pfizer.

Figures

Figure 1
Figure 1
Pharmacist’s role in the HIV cascade of care Adapted from Ehrenkranz et al. AEs, adverse effects; ART, antiretroviral therapy; DDIs, drug-drug interactions; PEP, postexposure prophylaxis; PrEP, pre-exposure prophylaxis; TasP, treatment as prevention; U=U, undetectable = untransmittable.
Figure 2
Figure 2
Factors associated with virologic failure

Similar articles

Cited by

  • Un monde sans la Revue des Pharmaciens du Canada - Canadian Pharmacists Journal. .
    Le comité consultatif de rédaction de la RPC-CPJ; Tsuyuki RT, Al Hamarneh YN, Austin Z, Barry A, Chang F, Grindrod K, Jorgenson D, Kung JY, Lalonde L. Le comité consultatif de rédaction de la RPC-CPJ, et al. Can Pharm J (Ott). 2025 Apr 28;158(3):127-130. doi: 10.1177/17151635251329747. eCollection 2025 May-Jun. Can Pharm J (Ott). 2025. PMID: 40309661 Free PMC article. No abstract available.
  • A world without the Canadian Pharmacists Journal - Revue des Pharmaciens du Canada. . .
    Editorial Advisory Board of CPJ-RPC; Tsuyuki RT, Al Hamarneh YN, Austin Z, Barry A, Chang F, Grindrod K, Jorgenson D, Kung JY, Lalonde L. Editorial Advisory Board of CPJ-RPC, et al. Can Pharm J (Ott). 2025 Apr 28;158(3):123-126. doi: 10.1177/17151635251329744. eCollection 2025 May-Jun. Can Pharm J (Ott). 2025. PMID: 40309662 Free PMC article. No abstract available.

References

    1. Samji H, Cescon A, Hogg RS, et al.. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013;8(12):e81355. - PMC - PubMed
    1. Marcus JL, Leyden WA, Alexeeff SE, et al.. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016. JAMA Netw Open 2020;3(6):e207954. - PMC - PubMed
    1. Gueler A, Moser A, Calmy A, et al.. Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population. AIDS 2017;31(3):427-36. - PMC - PubMed
    1. Schouten J, Wit FW, Stolte IG, et al.. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis 2014;59(12):1787-97. - PubMed
    1. Brunetta JM, Baril JG, de Wet JJ, et al.. Cross-sectional comparison of age- and gender-related comorbidities in people living with HIV in Canada. Medicine 2022;101(28):e29850. - PMC - PubMed

LinkOut - more resources